Dermata Therapeutics, Inc. Logo

Dermata Therapeutics, Inc.

Medical dermatology company developing and commercializing OTC skin care products.

DRMA | US

Overview

Corporate Details

ISIN(s):
US2498451085
LEI:
Country:
United States of America
Address:
3525 DEL MAR HEIGHTS RD., #322, 92130 SAN DIEGO

Description

Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dermata Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dermata Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dermata Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

KOWA CO.,LTD. Logo
A diversified manufacturer and trader in healthcare, optical products, and hospitality.
Japan
7807
K Pharma,Inc. Logo
Develops iPS cell-derived treatments for central nervous system disorders.
Japan
4896
Kringle Pharma,Inc. Logo
Develops HGF-based regenerative medicines for rare and intractable diseases.
Japan
4884
Krka Logo
An international generic pharmaceutical company developing human and animal health products.
Slovenia
KRKG
Krystal Biotech, Inc. Logo
Commercial-stage biotech developing genetic medicines for severe and rare diseases.
United States of America
KRYS
Kubota Pharmaceutical Holdings Co., Ltd. Logo
A clinical-stage company developing drugs and devices for ophthalmic diseases.
Japan
4596
KUKJEON PHARMACEUTICAL Co.,Ltd Logo
Develops and manufactures APIs and chemical materials for the electronics industry.
South Korea
307750
Kukje Pharma Co., Ltd. Logo
Manufactures and distributes pharmaceuticals, cosmetics, and health supplements.
South Korea
002720
Kuros Biosciences Ltd. Logo
Develops biologic technologies for tissue repair and bone regeneration.
Switzerland
KURN
Develops and sells health foods, supplements, cosmetics, and personal care items.
South Korea
086220

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.